New study sheds light on vision loss in rare genetic brain disorders

NCT ID NCT07019558

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how spinocerebellar ataxia (SCA) affects the eyes and vision. Researchers will examine 60 adults with SCA types 1, 2, 3, or 27B, including those with early symptoms and those who are not yet symptomatic. The goal is to measure vision changes and eye damage using tests like eye exams and scans, helping to better understand these rare neurological diseases.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINOCEREBELLAR ATAXIA TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebellar ataxia Machado-Joseph disease spinocerebellar ataxia 27B, late-onset spinocerebellar ataxia type 1 spinocerebellar ataxia type 2 Spinocerebellar Ataxias

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Montpellier - Hôpital Gui de Chauliac

    RECRUITING

    Montpellier, Hérault, 34000, France